On 4 February the Gabinete Técnico Farmacéutico M. Camps and consultancy Azierta organise the webinar "Vigilance and post-marketing of medical devices".
This training, which will be held online for registered users -attendance is free of charge, subject to registration- will provide an overview of regulation and the steps to be taken to carry out PS monitoring.
The market surveillance and monitoring are an essential part of the marketing of medical devices.This is a sector in continuous innovation and of great importance in the European and Spanish market.
The webinar will be moderated by:
- Mercè Camps. CEO and founder of the Technical Pharmaceutical Cabinet MCamps
- Olegario Cuevas. Healthcare Business Manager at Azierta
The webinar presentation will be conducted by:
- Silvia de Andrés. Medical Devices Officer
- Alberto Orós. Technical Consultant
Surveillance and marketing of medical devices:
webinar programme
-
-
- Introduction
- Surveillance system
- Incident management
- Security corrective actions (FSCA) and security notices (FSN)
- Trend reporting
- Post-market surveillance system
- Periodic Security Update Report (PSUR)
- Post Market Monitoring Report (PMSR)
- Post-marketing clinical follow-up
-
Latest articles in our blog
RAPEX report 27/3/2015: Sweden withdraws make-up remover
In this week's Rapex, published on Friday 27 March, we report that 7 Spanish products have been banned: a climbing protection carabiner, a pair of chemicals for e-cigarettes, a baby seat, toys and clothing for children, a pair of...
GTF participates in Infarma 2015
This week saw the 27th European Pharmacy Congress and Exhibition, In pharma 2015, organised at the Fira de Barcelona by the Col-legi de Farmacèutics de Barcelona (COFB), the Colegio Oficial de Farmacéuticos de Madrid (COFM) and Interalia, the company organising the event...
Rapex report 20/03/2015: 4 cosmetics withdrawn
In this week's RAPEX, 43 products have been banned across the EU, 12 of them in Spain. From GTF we report that the number of products in Spain -more than 25% of the total list- has been unusually high, and it must be said that, although we are aware of the...